Loading...

Knight Therapeutics Inc.

KHTRF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$5.40
$0.00(0.00%)
U.S. Market opens in 7h 38m

Knight Therapeutics Inc. (KHTRF) Stock Overview

Explore Knight Therapeutics Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap529.6M
P/E Ratio-130.54
EPS (TTM)$-0.04
ROE-0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$5.16
3 Months$5.03
1 Year Target$4.63

KHTRF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Knight Therapeutics Inc. (KHTRF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 58.08, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $4.63.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -130.54 and a market capitalization of 529.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
0.04%
1-Month Change
-2.49%
3-Month Change
24.76%
6-Month Change
30.48%
Year-to-Date (YTD) Change
24.18%
1-Year Change
21.12%
3-Year Change
56.13%
5-Year Change
26.51%
All-Time (Max) Change
-2.31%

Contact Information

https://www.gud-knight.com
514-484-4483
3400 De Maisonneuve Boulevard West, Montreal, QC, H3Z 3B8

Company Facts

745 Employees
IPO DateApr 3, 2014
CountryCA
Actively Trading

Frequently Asked Questions